Purchase Order HHSN302201600189P

<p>The National Human Genome Research Institute issued a purchase order to Qiagen, LLC on August 17, 2016, for $4,285.40 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 23, 2020. No set-aside was applied to this order. The source does not specify the particular products or services procured under this purchase order.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>

The National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,896.00 firm fixed-price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB services. The contract has an ultimate completion date of November 30, 2024 and was awarded on December 1, 2023. This award does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided various...

This is a $31,481 firm-fixed-price BPA call contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract has an ultimate completion date of April 30, 2017 and does not utilize a set-aside designation. Qiagen is a manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions,...

The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $15,090 on July 28, 2017, with ultimate completion by August 27, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The purchase covers molecular diagnostics products and consumables, consistent with Qiagen's core offerings in DNA/RNA extraction kits, reagents, and related laboratory supplies supporting the Clinical Center's biomedical research and diagnostic...

This purchase order award from the Department of Health and Human Services' National Institutes of Health Clinical Center to Qiagen, LLC is for $10,847.20 to support library preparation in next generation sequencing assays for clinical center patients. Qiagen will provide products and services for DNA/RNA extraction and sample preparation to support the agency's biomedical research and public health programs. As an international provider of molecular diagnostics technologies, Qiagen has...

This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V., for $14,921.70. The contract is for library preparation items needed for next-generation sequencing assays for NIH Clinical Center patients. The order has a completion date of November 23, 2024. Qiagen is an international provider of sample and assay technologies that has previously provided DNA/RNA extraction kits, next-generation sequencing,...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $44,005 purchase order to Qiagen, LLC to procure a QIACUITY ONE, 5PLEX digital PCR system with trade in of a RainDrop digital PCR system. Qiagen, LLC will deliver the requested products and services under a firm fixed price contract running from April 15, 2022 through May 31, 2022. As the parent company, Qiagen N.V. ultimately benefits from this contract to supply...

This is a $3,156.48 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC for the delivery of genomic DNA isolation kits. The contract is not set aside for a specific business type and was awarded on July 28, 2015 with a completion date of August 3, 2015. Qiagen, LLC is a division of the multinational biotechnology company Qiagen N.V., which provides sample and assay technologies to support federal agencies' biomedical...

This is a $6,702 firm fixed price contract awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is a Blanket Purchase Agreement (BPA) call, with an ultimate completion date of April 30, 2018. Qiagen, LLC is a subsidiary of the parent company Qiagen N.V., which has a significant federal contracting...